Interim CEO Named Permanent Leader at Tango Therapeutics Post author:Sam Post published:September 24, 2017 Post category:BioPharma September 25, 2017By Mark Terry, BioSpace.com Breaking News… Source: BioSpace You Might Also Like Johnson & Johnson Yanks Plans for First R&D Facility in the UK November 27, 2017 No Doubt: This is the Top Gene-Sequencing Stock to Buy This Year April 20, 2017 Cambridge's Neon Therapeutics Completes $106M Crossover Series B Funding Round December 6, 2017
